For Healthcare Professionals

As a professional, Eisai aims to support you in the treatment of your patients. In this section you will find information, including: Summary of Product Characteristics (SPC) and Product Information Leaflets (PIL).

If you require further information regarding one of our products, please use the Medical Information Enquiry Form.

Please follow the links to find further details of the medicines available in the UK.

Reporting Adverse Events

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard

Adverse events should also be reported to Eisai Ltd on one of the options below:
+44 (0)208 600 1400
EUmedinfo@eisai.net

Oncology

Neurology

Fycompa^®
perampanel Tablets Great Britain Suspension Great Britain Tablets Northern Ireland Suspension Northern Ireland Tablets Great Britain Suspension Great Britain Tablets Northern Ireland Suspension Northern Ireland
Inovelon^®
rufinamide Tablets Great Britain Suspension Great Britain Tablets Northern Ireland Suspension Northern Ireland Tablets Great Britain Suspension Great Britain Tablets Northern Ireland Suspension Northern Ireland
Aricept^®
donepezil hydrochloride Summary of Product Characteristics Patient Information Leaflet
Aricept Evess^®
donepezil hydrochloride Summary of Product Characteristics Patient Information Leaflet
Zonegran^®
zonisamide Summary of Product Characteristics Great Britain Summary of Product Characteristics Northern Ireland Patient Information Leaflet Great Britain Patient Information Leaflet Northern Ireland

Others

Pariet^®
rabeprazole Summary of Product Characteristics Patient Information Leaflet